2区TEVAR+开放LSA血运重建与2区胸主动脉分支支架早期及中期结局比较
OBJECTIVES: The Gore TAG Thoracic Branch Endoprosthesis (TBE) was the first commercially available device designed for thoracic aortic repair to offer a fully endovascular alternative to open left subclavian artery (LSA) revascularization.…
要点
- 2区TBE较开放LSA血运重建缩短手术时间和住院时间,并降低围术期主要不良事件。
- 两组1年免于全因死亡、内漏和再干预的比例相当,LSA通畅率均优良。
- TBE为解剖适合患者提供全腔内选择,开放血运重建可保留给解剖不适合者。
核心结论
- 2区TBE与2区TEVAR联合开放LSA血运重建相比,围术期发病率更低,1年结局相似。
- 2区TBE是解剖适合患者的可行选择,术后结局和1年LSA通畅率与开放血运重建相当,且住院时间更短。
- 仍需更长期研究验证TBE修复的持续安全性和耐久性。
研究设计与样本
- 双三级转诊中心回顾性分析,纳入2011–2024年所有连续接受2区TEVAR联合LSA血运重建和2区TBE的患者。
主要发现
- 队列总体中位年龄67岁,66.3%为男性。
- 组1中位随访37.2个月(IQR 15.2–75.8),组2为14.2个月(IQR 3.7–23.3)。
- Kaplan-Meier分析显示两组1年免于全因死亡、内漏和再干预的比例相当;两组1年LSA原发通畅率均优良(组1 95.3%,组2 100%)。
临床怎么用
- 对于解剖适合的患者,2区TBE可作为一种即用型经皮选择,避免颈部切口及其输血、神经和淋巴并发症。
- 开放LSA血运重建可保留用于解剖不适合TBE的患者。
- TBE适用于动脉瘤、夹层相关和创伤性病变,但需更长期随访确认耐久性和逆撕风险。
局限性
- 回顾性设计。
- 两组随访时间不一致,组2中位随访明显短于组1。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The Gore TAG Thoracic Branch Endoprosthesis (TBE) was the first commercially available device designed for thoracic aortic repair to offer a fully endovascular alternative to open left subclavian artery (LSA) revascularization. In this study, we compared early and mid-term outcomes of zone 2 thoracic endovascular aortic repair (TEVAR) with open LSA revascularization and zone 2 TBE. METHODS: This retrospective analysis was conducted at 2 tertiary referral centers and included all consecutive patients who underwent zone 2 TEVAR with LSA revascularization and zone 2 TBE between 2011 and 2024. Patient characteristics, procedural details, and 1-month and 1-year outcomes were compared across cohorts. Statistical significance was set at P < .05. RESULTS: Forty-six patients underwent zone 2 TEVAR with open LSA revascularization (group 1), and 40 patients underwent zone 2 TBE (group 2). The overall median age of the cohort was 67 years, and 66.3% of the patients were male. The mean total operative time and length of stay were significantly shorter in the zone 2 TBE group (144.3 ± 63.7 vs 341.8 ± 106.8 minutes, P < .001; 2.9 ± 2.1 vs 4.1 ± 2.8 days, P = .025). Patients who underwent zone 2 TEVAR with LSA revascularization were more likely to experience major adverse events (MAEs) during the perioperative period (32.6% vs 12.5%, P = .028). The median follow-up time was 37.2 months (interquartile range [IQR], 15.2-75.8) for group 1 and 14.2 months (IQR, 3.7-23.3) for group 2. Kaplan-Meier analyses showed comparable 1-year freedom from all-cause mortality, endoleak, and reintervention between groups. Both groups achieved excellent primary LSA patency rates at 1 year (group 1, 95.3%; group 2, 100%). CONCLUSIONS: Zone 2 TBE was associated with reduced perioperative morbidity and similar 1-year outcomes to those of zone 2 TEVAR with open LSA revascularization. These findings show that zone 2 TBE is a feasible option in anatomically suitable patients, with postoperative outcomes and LSA patency through 1 year comparable to zone 2 TEVAR, and is associated with a shorter length of stay. Further long-term investigations are required to validate the sustained safety and durability of TBE repair.Clinical ImpactThis two-center, real-world comparison shows that zone 2 thoracic endovascular aortic repair (TEVAR) with the Gore TAG Thoracic Branch Endoprosthesis (TBE) achieves technical success, left subclavian artery patency, and 1-year freedom from mortality, endoleak, and re-intervention comparable to zone 2 TEVAR with open left subclavian revascularization, while shortening hospital stay and reducing perioperative morbidity by avoiding cervical exposure and its transfusion, nerve, and lymphatic complications. For clinicians, TBE offers an off-the-shelf, percutaneous option for anatomically suitable patients with aneurysmal, dissection-related, and traumatic pathology, reserving open revascularization for unsuitable anatomy. Longer follow-up is needed to confirm durability and clarify the risk of retrograde dissection.
引用
- Neves PJF, Hanif H, Taheri B, et al. Early and Mid-Term Outcomes of Zone 2 Thoracic Endovascular Aortic Repair With Open Left Subclavian Revascularization Versus Zone 2 Thoracic Branch Endoprosthesis. J Endovasc Ther. 2026. PMID: 42803214. doi:10.1177/15266028261489513
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。